Published in Sci Rep on February 12, 2016
Paradigm Shift is the Normal State of Pharmacology. EC Pharmacol Toxicol (2016) 0.75
The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacol Rev (2017) 0.75
Signal transduction by the JNK group of MAP kinases. Cell (2000) 18.24
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev (1999) 9.02
Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science (2000) 5.20
Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A (2001) 4.56
Scaffold proteins: hubs for controlling the flow of cellular information. Science (2011) 4.00
Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc Natl Acad Sci U S A (2000) 3.95
The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell (1999) 3.67
The JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol (1999) 3.18
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther (2006) 3.15
Signal transduction: hanging on a scaffold. Curr Opin Cell Biol (2000) 2.96
The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol (2010) 2.72
Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure (2001) 2.66
Designing customized cell signalling circuits. Nat Rev Mol Cell Biol (2010) 2.64
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature (2015) 2.43
Scaffold proteins of MAP-kinase modules. Oncogene (2007) 2.30
Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol (2006) 2.15
Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem (2006) 1.97
Crystal structure of cone arrestin at 2.3A: evolution of receptor specificity. J Mol Biol (2005) 1.82
Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr Biol (1999) 1.81
JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron (2012) 1.80
G-protein-coupled receptors: turn-ons and turn-offs. Curr Opin Neurobiol (1998) 1.54
Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. J Biol Chem (2006) 1.53
Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol (2007) 1.52
Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. J Mol Biol (2011) 1.31
How does arrestin assemble MAPKs into a signaling complex? J Biol Chem (2008) 1.30
Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc Natl Acad Sci U S A (2012) 1.27
Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem (1993) 1.27
Conformation of receptor-bound visual arrestin. Proc Natl Acad Sci U S A (2012) 1.24
Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3. J Biol Chem (2001) 1.23
Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci (2012) 1.05
Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol Chem (2012) 1.04
Regulatory modules that generate biphasic signal response in biological systems. Syst Biol (Stevenage) (2004) 0.99
Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry (2011) 0.99
Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex. Biochemistry (2011) 0.97
Identification of arrestin-3-specific residues necessary for JNK3 kinase activation. J Biol Chem (2011) 0.96
JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinases. J Biol Chem (2013) 0.89
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists. Methods Enzymol (2010) 0.88
Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. J Biol Chem (2013) 0.85
Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains. Cell Signal (2014) 0.85
Alzheimer's Disease: JNK3 as new target in AD? Nat Rev Drug Discov (2012) 0.77